Pharmaceutical Industry Business Confidence Report H1 2016

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1950

In total, 43% of pharmaceutical industry business executives expect the global economy to be stable in H1 2016 (January 2016–June 2016). Furthermore, 33% of survey respondents anticipate a favorable or very favorable economic environment Overall, 83% of respondents who operate in Europe are optimistic over company growth prospects, while no executives anticipate a negative impact on the industry in the region Business executives operating in the Rest of the World region anticipate the highest increase in staff headcount growth over the next six months In H1 2016, the majority of business executives from North America are concerned about the performance of North American economies, the performance of the Eurozone, and cyber crime Survey results reveal that 41% of pharmaceutical industry respondents who operate in Asia-Pacific expect an increase of 1–5% in the budget for pharmaceutical equipment during 2016

Scope

Kable’s pharmaceutical Industry Business Confidence Survey H1 2016 examines executives’ opinion on the business environment over January–June 2016. It also highlights existing economic conditions, supplier price variations, sales performance, industry and company growth outlook, spending patterns, and key priorities. Additionally, the report includes trends in the pharmaceutical equipment market, analysis of the procurement budget allocations, and leading suppliers of pharmaceutical equipment.

What else does this report offer

• Current state of the global economy: examines prevailing economic conditions globally and across various regions

• Company and industry growth outlook: provides industry executives’ expectations towards the growth prospects of their company and the industry over the next six months

• Change in customer confidence: analyzes pharmaceutical industry executives’ opinion about the change in customer confidence during H1 2016

• Supplier prices projection: determines expected change in supplier prices across various categories and their impact on business confidence

• Change in staff headcount and sales performance: tracks expected change in staff headcount and sales for H1 2016 among industry executives globally

• Significant investment activities: highlights various areas in which industry executives intend to invest over the next six months

• Business concerns: provides information about potential business concerns indicated by survey respondents for H1 2016

• Key priorities: identifies the top priorities of industry executives operating in various regions

• Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories

• Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2015 and expectations for 2016

Reasons to Buy

Helps organizations to make effective business strategy decisions by knowing the prevailing business conditions and sentiment within the pharmaceutical industry

Organizations will be supported in business expansion decisions by providing information about projected change in sales performance and supplier prices

Helps to improve operational efficiency of the organization by knowing about key priorities and the main concerns of pharmaceutical industry executives

Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016

Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment

Johnson & Johnson (Pty) Ltd
Albany Molecular Research (AMRI)
New York Center for Nanomedicine Research (NYCNMR)
GlaxoSmithKline (GSK)
Mylan
Shire
Baxalta

Table of Contents

Introduction

Definitions

Methodology and sample size

Respondent profile

Economic State, growth prospects and customer confidence

Existing economic environment

Industry and company growth outlook

Expected change in customer confidence

Supplier prices, staff headcount and sales performance

Supplier prices expectations

Anticipated change in staff head count and sales projections

Anticipated change in spend on key activities

Business concerns and organizational priorities

Level of concerns and expected impact

Significance of potential business priorities

Procurement budget and expenditure outlook

Purchase preferences for pharmaceutical equipment

Frequency of investments towards various equipment categories

Procurement of number of pieces of equipment

Average expenditure per purchase

Allocation of investment for equipment purchases

Distribution of procurement budget between capital and operating expenditure

Change in procurement budget expenditure

Variation in pharmaceutical equipment budget from 2015 to 2016

Leading suppliers across pharmaceutical equipment types

Appendix

Table

N/A

Figures

Figure 1: Current economic condition – Overall

Figure 2: Current economic condition – Region

Figure 3: Current economic condition – Those who operate and do not operate in a region

Figure 4: Industry and company growth prospects – Overall

Figure 5: Industry and company growth prospects – Overall – In detail

Figure 6: Industry and company growth prospects – Region

Figure 7: Anticipated variation in customer confidence – Overall

Figure 8: Anticipated variation in customer confidence – Region

Figure 9: Projected change in supplier prices – Raw Materials – Overall and regional

Figure 10: Projected change in supplier prices – Semi-finished products – Overall and regional

Figure 11: Projected change in supplier prices – Packaging – Overall and regional

Figure 12: Projected change in supplier prices – Ingredients – Overall and regional

Figure 13: Staff headcount and sales outlook – Regional

Figure 14: Expenditure projection on key activities – Overall

Figure 15: Top five business concerns – Region

Figure 16: Business concerns – Overall and regional

Figure 17: Business concerns – Overall and regional

Figure 18: Top five organizational priorities – Region

Figure 19: Organizational priorities – Overall and region

Figure 20: Purchase preferences – Region

Figure 21: Frequency of investments – Overall

Figure 22: Procurement of number of pieces of equipment – Overall

Figure 23: Average expenditure per purchase – Overall

Figure 24: Investment allocation for equipment purchases – Region

Figure 25: Distribution of procurement budget – Region

Figure 26: Change in procurement budget expenditure – Region

Figure 27: Change in pharmaceutical equipment budget – Region

Figure 28: Leading suppliers across pharmaceutical equipment types – Overall

Frequently asked questions

Pharmaceutical Industry Business Confidence Report H1 2016 standard reports
Currency USD
$1,950

Can be used by individual purchaser only

$5,850

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Pharmaceutical Industry Business Confidence Report H1 2016 in real time.

  • Access a live Pharmaceutical Industry Business Confidence Report H1 2016 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.